BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
Recombinant endoglycoceramidase II is a glycolipid-specific hydrolase derived from Rhodococcus sp. and its recombinant protein is expressed in Rhodococcus erythropolis.
Unit Definition
One unit will hydrolyze 1 μmol of ganglioside GM1 per minute at pH 5.5 at 37°C.
Expression System
Rhodococcus erythropolis
Source
Rhodococcus sp.
Reaction Conditions
50 mM Sodium acetate containing 0.4% Triton X-100, pH 5.5
Production Methods
Fermentation
Detection Method
The mixture of recombinant endoglycoceramidase II and 100 nmol of GM1 in 50 μL is incubated at 37°C for 15 min. Quantification of the reducing end of the released oligosaccharides is determined using the modified Somogyi-Nelson method. Glucose is determined by a modified Somogyi-Nelson method.
Sensitivity
Heat sensitive
Concentration
100 mU per vial (2 mU/μL)
Form
Colorless to almost colorless clear liquid
Titer
≥ 100 mU/vial
Buffer
20 mM Sodium phosphate, 50 mM NaCl buffer, pH 7.0
Preservative
None
Stabilizer
None
pH
5.5
Applications
Recombinant endoglycoceramidase II can be used to cleave the glycosidic linkage between oligosaccharide and ceramide of various glycosphingolipids (GSLs).
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.